<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02518685</url>
  </required_header>
  <id_info>
    <org_study_id>DTC006</org_study_id>
    <nct_id>NCT02518685</nct_id>
  </id_info>
  <brief_title>ENDObesity® II Study: TransPyloric Shuttle® System for Weight Loss</brief_title>
  <official_title>Endoscopic Treatment for Weight Reduction in Patients With Obesity Using the TransPyloric Shuttle® System: A Multicenter, Prospective, Randomized, Double-Blind, Sham-Controlled, Parallel-Design Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BaroNova, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BaroNova, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical research trial is to study safety and effectiveness of the
      TransPyloric Shuttle System (TPSS) for weight reduction in patients who are considered
      medically obese.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean percent Total Body Weight Loss (% TBL) between Treatment and Control group</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of subjects with greater than or equal to 5% TBL in Treatment group</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">270</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>TransPyloric Shuttle (TPS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TransPyloric Shuttle plus lifestyle counseling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham procedure plus lifestyle counseling.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TransPyloric Shuttle</intervention_name>
    <arm_group_label>TransPyloric Shuttle (TPS)</arm_group_label>
    <other_name>TPS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>lifestyle counseling</intervention_name>
    <arm_group_label>TransPyloric Shuttle (TPS)</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham procedure</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female subjects between the ages of 22 to 60

          -  A BMI between 30.0 to 40.0 kg/m2, inclusive. Subjects with a BMI of 30.0 kg/m2 to 34.9
             kg/m2 are required to have one or more obesity-related comorbidities

          -  History of obesity for at least 2 years, with history of failure of medically or
             commercially supervised weight loss program

          -  &lt; 5% change in body weight for at least 3 months

          -  Negative pregnancy test, agree to be on birth control for the duration of
             participation

          -  Informed consent

          -  Willing and able to comply with study procedures

        Exclusion Criteria:

          -  Pregnancy or nursing

          -  Hormonal or genetic cause for obesity

          -  Prior history of any GI surgery or endoscopic intervention

          -  Chronic use of medications likely to contribute to weight gain or prevent weight loss

          -  Gastric or duodenal ulcers

          -  Positive for H. pylori

          -  History of severe dyspepsia

          -  GI tract motility disorders

          -  History of inflammatory disease of GI tract, coeliac disease, pancreatitis, portal
             hypertension, cirrhosis, and/or varices

          -  Diabetes treated with insulin

          -  HbA1c &gt;7.5%

          -  Uncontrolled thyroid and adrenal gland disease or uncontrolled hypertension

          -  History of certain cardiac events

          -  Localized or systemic infection

          -  Anemia

          -  History of asthma likely to require systemic steroid therapy

          -  Autoimmune connective tissue disorders or immunocompromised

          -  History of malignancy except non-melanoma skin cancer

          -  Continuous use of ulcerogenic medication

          -  On anticoagulation or antiplatelet therapy

          -  Use of weight-loss medication

          -  In other weight-loss program

          -  Unable to take proton pump inhibitor

          -  Abnormal laboratory values or EKG

          -  Inability to walk at least 0.8 kilometers per day

          -  Planned surgical procedure that can impact the conduct of the study

          -  Known allergy to any component materials in the TPSS

          -  Smoker or user of nicotine product

          -  Substance abuse

          -  Severe, uncontrolled psychiatric illness

          -  Recent inpatient psychiatric treatment

          -  Moderate depression

          -  Bulimia nervosa or binge eating disorder

          -  Participation in another clinical study

          -  Employee or family member of Sponsor or study staff

          -  Have any endoscopic exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>HonorHealth Bariatric Center</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33166</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook Medicine</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MidSouth Bariatrics</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ENDObesityStudy.com</url>
    <description>For more information about the study and to see if you qualify</description>
  </link>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2015</study_first_submitted>
  <study_first_submitted_qc>August 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2015</study_first_posted>
  <last_update_submitted>May 24, 2018</last_update_submitted>
  <last_update_submitted_qc>May 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Weight loss</keyword>
  <keyword>Device</keyword>
  <keyword>Non-surgical</keyword>
  <keyword>Endoscopic</keyword>
  <keyword>TransPyloric Shuttle</keyword>
  <keyword>TPS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

